Home > Pharmaceutical > Generic Drugs

Generic Drugs (150)

Mental Disease (101)

Neurodegenerative Disease (217)

Obesity Treatment (40)

OTC Drug (119)

Pharmaceutical Companies (385)

Prescription Drugs (311)

Regulation (236)

Vaccines (150)

Veterinary Medicine (30)

Generic Drugs Market Research Reports

We offer market research, industry forecasts, and business analysis in the Generic Drugs as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.


All (150) Biosimilar (60)

Filter

Title Search

1 - 25 of 150 Products

Sort by

Display

Post-Patent Generic and Biosimilar Defense Strategies: Harnessing Competitive Tactics to Mitigate Revenue Erosion Product code:121988
Published by	Cutting Edge Information
Published	May 13, 2013	Content info	233 Pages
Price	US $ 7695

Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors Product code:146105
Published by	La Merie Publishing
Published	May 1, 2013	Content info	301 Pages
Price	US $ 2100

Biosimilars And Follow-On Biologics: World Market 2013-2023 Product code:204743
Published by	Visiongain
Published	will be released on April 30, 2013	Content info	235 Pages
Price	US $ 2738

Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and Kazakhstan: Development forecasts for 2013-2015 Product code:179466
Published by	PMR
Published	April 30, 2013	Content info	168 Pages
Price	US $ 2800

PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 Product code:267066
Published by	GlobalData
Published	March 31, 2013	Content info	141 Pages
Price	US $ 2995

PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013 Product code:267065
Published by	GlobalData
Published	March 31, 2013	Content info	105 Pages
Price	US $ 3995

Biosimilars in Emerging Markets Product code:268895
Published by	Doctor's Guide Publishing Limited (FirstWord Pharma)
Published	March 1, 2013	Content info	226 Pages
Price	US $ 665

Russia Generics and Biosimilars Product code:268435
Published by	Datamonitor
Published	March 1, 2013	Content info	22 Pages
Price	US $ 1900

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Product code:257409
Published by	GBI Research
Published	December 14, 2012	Content info	Pages: 78
Price	US $ 3500

Global Biosimilars Market - Products, Applications and Regulations Product code:255553
Published by	Industry Experts
Published	November 26, 2012	Content info	354 Pages
Price	US $ 4320

Generic Drugs: World Market 2013-2023 Product code:220569
Published by	Visiongain
Published	November 13, 2012	Content info	149 Pages
Price	US $ 2497

Opportunity Analysis for Biosimilars - South Korea Product code:249890
Published by	Frost & Sullivan
Published	September 5, 2012	Content info
Price	US $ 6500

Charting the Biosimilar and Biobetter Development Pipeline Product code:250781
Published by	Doctor's Guide Publishing Limited (FirstWord Pharma)
Published	September 1, 2012	Content info	428
Price	US $ 1950

Generics Analysis: Key Patent Case Reviews Product code:250554
Published by	Datamonitor
Published	August 17, 2012	Content info	Pages: 16
Price	US $ 1900

Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016 Product code:254654
Published by	Huidian Research (Beijing BeiFuYuan Information Consulting Co., Ltd)
Published	August 16, 2012	Content info	Pages: 70
Price	US $ 1800

EU Biosimilars Database Product code:250571
Published by	Datamonitor
Published	August 10, 2012	Content info
Price	US $ 5700

Generics: Global Industry Guide Product code:251357
Published by	MarketLine
Published	August 1, 2012	Content info	Pages: 253
Price	US $ 1495

Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings Product code:246722
Published by	GBI Research
Published	July 10, 2012	Content info	Pages: 82
Price	US $ 3500

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth Product code:246719
Published by	GBI Research
Published	July 10, 2012	Content info	Pages: 141
Price	US $ 3500

Global Biosimilars Market Report: 2012 Edition Product code:142228
Published by	Koncept Analytics
Published	July 10, 2012	Content info	40 Pages
Price	US $ 800

Generics: US Regulatory Update Product code:248076
Published by	Datamonitor
Published	June 26, 2012	Content info	Pages: 31
Price	US $ 3800

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Product code:245749
Published by	GBI Research
Published	June 25, 2012	Content info	Pages: 88
Price	US $ 3500

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth Product code:245748
Published by	GBI Research
Published	June 25, 2012	Content info	Pages: 110
Price	US $ 3500

Inhalation & Nasal Spray Generic Drugs 2012 Product code:115822
Published by	Espicom Business Intelligence
Published	June 11, 2012	Content info	Pages: 100
Price	US $ 1740

Cancer Generics Market Analysis Product code:212646
Published by	RNCOS E-Services Pvt. Ltd.
Published	June 1, 2012	Content info	75 Pages
Price	US $ 1000

User Guide About Us Policies Site Map

Int'l: +1-860-674-8796 US: +1-866-353-3335 (Toll Free) | EU: +32-2-535-7543 | SG: +65-6223-2436